TickerFacts.

Company research / LH

Labcorp Holdings Inc. (LH)

Build a valuation ↗↓ Download CSV

SEC name LABCORP HOLDINGS INC. · CIK 0000920148 · NYSE · Services-Medical Laboratories

  • Sector Services
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Labcorp Holdings Inc. reported revenue of $13.95B. Revenue grew 7.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $14.35B.

Key ratios (year ended 2025-12-31)

28.8%
Gross margin
9.9%
Operating margin
6.3%
Net margin
10.2%
Return on year-end equity
7.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-30

Headquarters locality: Burlington · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$14.35B$13.95B$13.01B$12.16B$11.86B$13.14B$13.98B$11.55B$11.33B$10.31B$9.55B
Cost of Revenue$10.20B$9.94B$9.38B$8.80B$8.15B$8.14B$9.03B$8.30B$8.16B$7.22B$6.70B
Gross Profit$4.14B$4.01B$3.62B$3.36B$3.71B$4.99B$4.95B$3.25B$3.18B$3.09B$2.85B
Operating Income$1.50B$1.38B$1.09B$725.60M$1.44B$3.05B$2.45B$1.33B$1.33B$1.31B$1.27B
Depreciation & Amortization$696.30M$681.10M$643.50M$577.30M$537.20M$577.00M$624.70M$577.20M$552.10M$533.20M$499.20M
EBITDA$2.19B$2.07B$1.73B$1.30B$1.97B$3.63B$3.07B$1.91B$1.88B$1.84B$1.77B
Net Income$1.00B$876.50M$746.00M$418.00M$1.28B$2.38B$1.56B$823.80M$883.70M$1.23B$711.80M
EPS (Diluted)n/a$10.46$8.84$4.77$13.97$24.39$15.88$8.35$8.61$11.81$6.82
Total Assets$18.53B$18.39B$18.38B$16.73B$20.16B$20.39B$20.07B$18.05B$16.19B$16.67B$14.25B
Total Liabilities$9.91B$9.76B$10.31B$8.83B$10.04B$10.09B$10.61B$10.46B$9.19B$9.85B$8.73B
Long-Term Debtn/an/an/an/an/an/an/a$6.21B$6.00B$6.70B$5.78B
Shareholders' Equity$8.61B$8.62B$8.05B$7.88B$10.10B$10.27B$9.44B$7.64B$6.97B$6.80B$5.52B
Cash & Equivalents$141.80M$532.30M$1.52B$536.80M$320.60M$1.47B$1.32B$337.50M$426.80M$316.60M$433.60M
Operating Cash Flow$1.64B$1.64B$1.59B$1.33B$1.96B$3.11B$2.14B$1.44B$1.31B$1.50B$1.20B
Capital Expenditures$483.20M$434.50M$489.90M$453.60M$429.30M$421.50M$381.70M$400.20M$379.80M$312.90M$278.90M
Free Cash Flow$1.16B$1.21B$1.10B$874.10M$1.53B$2.69B$1.75B$1.04B$925.60M$1.19B$918.20M
Share Repurchases$701.80M$450.00M$250.10M$1.00B$1.10B$1.67B$100.00M$450.00M$700.00M$338.10M$43.90M
Dividends Paid$239.10M$240.70M$243.10M$254.00M$195.20Mn/an/an/an/an/an/a
Shares Outstanding80.90M82.20M83.40M83.90M88.20Mn/an/a97.20M98.90M101.90M102.70M
Dividends Per Sharen/a$2.88$2.88$2.88$2.16n/an/an/an/an/an/a
Weighted Average Diluted Sharesn/a83.80M84.40M87.60M91.60M97.50M98.00M98.60M102.60M103.90M104.30M
EPS (Basic)n/a$10.54$8.89$4.80$14.05$24.60$15.99$8.42$8.71$11.99$6.94

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView